ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 137 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 8.14 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $215,000 | -61.5% | 11,414 | -76.6% | 0.01% | -80.0% |
Q4 2017 | $558,000 | -17.0% | 48,767 | -11.0% | 0.04% | -26.2% |
Q3 2017 | $672,000 | -32.3% | 54,819 | -36.8% | 0.06% | -35.1% |
Q2 2017 | $993,000 | +214.2% | 86,692 | +470.8% | 0.09% | +213.3% |
Q1 2017 | $316,000 | -40.4% | 15,188 | -6.0% | 0.03% | -46.4% |
Q3 2016 | $530,000 | +129.4% | 16,162 | +130.9% | 0.06% | +55.6% |
Q4 2015 | $231,000 | +492.3% | 7,000 | +483.3% | 0.04% | +500.0% |
Q3 2015 | $39,000 | -39.1% | 1,200 | 0.0% | 0.01% | -33.3% |
Q2 2015 | $64,000 | +220.0% | 1,200 | +71.4% | 0.01% | +200.0% |
Q1 2015 | $20,000 | -37.5% | 700 | -36.4% | 0.00% | -40.0% |
Q4 2014 | $32,000 | – | 1,100 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |